VINCERX PHARMA INC

CUSIP: 92731L106 Class: COM NEW

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 631,397 Value ($000) $166 Avg Close — Range —
Q3 2024
Shares 631,424 Value ($000) $452 Avg Close — Range —
Q2 2024
Shares 631,421 Value ($000) $511 Avg Close — Range —
Q1 2024
Shares 631,490 Value ($000) $3,195 Avg Close — Range —
Q4 2023
Shares 1,709,656 Value ($000) $2,017 Avg Close — Range —
Q3 2023
Shares 2,062,926 Value ($000) $2,084 Avg Close — Range —
Q2 2023
Shares 2,062,950 Value ($000) $2,682 Avg Close — Range —
Q1 2023
Shares 2,064,892 Value ($000) $2,147 Avg Close — Range —
Q4 2022
Shares 2,074,271 Value ($000) $2,116 Avg Close — Range —
Q3 2022
Shares 13,895 Value ($000) $0 Avg Close — Range —
Q2 2022
Shares 36,126 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 29,792 Value ($000) $119 Avg Close — Range —